Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
Bioextrax Registered: revenue forecast sharply higher, EPS still negative
Bioextrax Registered plans to present the figures for the quarter ending 30.09.2025 on 21.11.2025. One analyst estimates EPS at -0.110 SEK (same level as last year) and expects revenue of 0.6 million SEK (+177% year-on-year). For the fiscal year a loss per share of -0.430 SEK (previously -0.520) and annual revenue of 2.1 million SEK are forecast. » More on finanzen.net
Financials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 11.73k | 70.82% |
| Gross profit | -456.6k | 3,491.77% |
| Net profit | -442.79k | 12.57% |
| EBITDA | -435.03k | 18.20% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €10.16m |
Number of shares | 47.67m |
52-week high/low | €0.33 - €0.15 |
| Dividends | No |
Beta | 1.43 |
P/E ratio | -5.39 |
PEG ratio | 17.00 |
P/B ratio | 9.30 |
P/S ratio | 204.66 |
Company profile
Bioextrax AB (publ) develops and commercializes a bio-based extraction platform technology. It harvests bioplastics (PHA) granules, organic hydrolyzed protein, keratin fibers, bio-oils, protein-rich by products, and amino acids from bacteria. The company was incorporated in 2014 and is based in Lund, Sweden.
| Name | BIOEXTRAX AB |
| CEO | Edvard Hall |
| Headquarters | Lund,
sn Sweden |
| Website | |
| IPO | 28/04/2020 |
| Employees | 14 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
Frankfurt | 85X0.F |
Düsseldorf | 85X0.DU |
Stockholm | BIOEX.ST |
München | 85X0.MU |
